TNFRSF17 and neoplasm: Furthermore, defects in antigen presentation, including downregulation or loss of major histocompatibility complex (MHC) class I molecules, impair the ability of cytotoxic T lymphocytes to recognize and eliminate tumor cells, enabling immune evasion independent of BCMA expression.